Abortion pill ruling could limit access nationwide, including California

A federal appeals court ruling restricts access to the abortion pill mifepristone, raising concerns about patient access in California and nationwide. The 5th U.S. Circuit Court of Appeals blocks providers from mailing prescriptions of mifepristone. Patients must now obtain the drug in person.